Blue Steens in July 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, hydroxychloroquine as a potential treatment has fallen further from favour whilst remdesivir is in high demand; dexamethasone has also stood its ground; 4 highly promising […]